Buscar

01/01/2025 Anti-PD-1 and anti-PD-L1 antibodies for glioma
de Melo, SM, da Silva, MEEN, Torloni, MR, Riera, R, De Cicco, K, Latorraca, CO, Pinto, ACPN. Anti-PD-1 and anti-PD-L1 antibodies for glioma. COCHRANE DATABASE OF SYSTEMATIC REVIEWS. 2025; (1)DOI:10.1002/14651858.CD012532.pub2. PMID:39777725. IF:9.400(Q1/1D).
01/04/2026 Comparative efficacy and safety of clozapine and olanzapine in schizophrenia and related disorders: An updated systematic review
Asenjo-Lobos, C, Arancibia, M, Cortés-Jofré, M, Huang, TM, Li, T, Madrid, E, Leucht, S. Comparative efficacy and safety of clozapine and olanzapine in schizophrenia and related disorders: An updated systematic review. PSYCHIATRY RESEARCH. 2026; 358DOI:10.1016/j.psychres.2026.116956. PMID:41579414. IF:3.900(Q1/2D).
01/02/2026 Grading of Recommendations, Assessment, Development, and Evaluation guidance 44: strategies to enhance the utilization of randomized and nonrandomized studies in evidence syntheses of healthinterventions
Cuello-Garcia, CA, Morgan, RL, Santesso, N, Alonso-Coello, P, Brignardello-Petersen, R, Schwingshackl, L, Brozek, JL, Katikireddi, SV, Munn, Z, Waddington, HS, Wilson, KC, Meerpohl, J, Morales, D, Neumann, I, Tugwell, P, Guyatt, G, Schünemann, HJ. Grading of Recommendations, Assessment, Development, and Evaluation guidance 44: strategies to enhance the utilization of randomized and nonrandomized studies in evidence syntheses of healthinterventions. JOURNAL OF CLINICAL EPIDEMIOLOGY. 2026; 190DOI:10.1016/j.jclinepi.2025.112086. PMID:41285282. IF:5.200(Q1/1D).
01/02/2026 The Risk of Bias in Vaccine Effectiveness (RoB-VE) project: introduction to a methodological initiative to improve risk-of-bias assessment and reporting in vaccine effectiveness research
Laurie, C, Coello, PA, Florez, ID, Le, M, Moher, D, Sadarangani, M, Sundaram, ME, Wells, G, Wilkinson, K, Dwan, K, Halperin, SA, Nicholls, SG, Reeves, BC, Waddington, HS, Shea, B, Brouwers, M, Sulis, G. The Risk of Bias in Vaccine Effectiveness (RoB-VE) project: introduction to a methodological initiative to improve risk-of-bias assessment and reporting in vaccine effectiveness research. JOURNAL OF CLINICAL EPIDEMIOLOGY. 2026; 190DOI:10.1016/j.jclinepi.2025.112088. PMID:41297718. IF:5.200(Q1/1D).